author-photo

Ashraf Z. Badros

University of Maryland, College Park

8

Papers

15

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study (Jul, 10.1007/s40123-020-00280-8, 2020)

2020 Ophthalmology and therapy
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)